tradingkey.logo

National Research Corp

NRC
14.700USD
+0.360+2.51%
Close 11/07, 16:00ETQuotes delayed by 15 min
333.06MMarket Cap
20.35P/E TTM

National Research Corp

14.700
+0.360+2.51%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of National Research Corp

Currency: USD Updated: 2025-11-07

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

National Research Corp's Score

Industry at a Glance

Industry Ranking
109 / 160
Overall Ranking
344 / 4614
Industry
Professional & Commercial Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

National Research Corp Highlights

StrengthsRisks
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of three primary solution categories: Marketing, Reputation and Experience. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. The Company's Experience solutions are provided on a subscription basis via a cross-continuum multi-mode digital platform. Its Reputation solutions allow healthcare organizations to share a picture of their organization.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 45.67%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 45.67%.
Fairly Valued
The company’s latest PE is 20.57, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 11.74M shares, decreasing 11.87% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 12.40K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-07

The company's current financial score is 6.89, which is lower than the Professional & Commercial Services industry's average of 7.31. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 34.61M, representing a year-over-year decrease of 3.38%, while its net profit experienced a year-over-year decrease of 27.53%.

Score

Industry at a Glance

Previous score
6.89
Change
0

Financials

4.76

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

10.00

Operational Efficiency

6.60

Growth Potential

6.65

Shareholder Returns

6.46

National Research Corp's Company Valuation

Currency: USD Updated: 2025-11-07

The company’s current valuation score is 6.14, which is lower than the Professional & Commercial Services industry's average of 7.13. Its current P/E ratio is 20.57, which is 92.79% below the recent high of 39.66 and 52.24% above the recent low of 9.83.

Score

Industry at a Glance

Previous score
6.14
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 109/160
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-07

There is no earnings forecast score for this company; the Professional & Commercial Services industry's average is 7.66.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

No Data
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-07

The company’s current price momentum score is 8.95, which is higher than the Professional & Commercial Services industry's average of 7.01. Sideways: Currently, the stock price is trading between the resistance level at 15.98 and the support level at 12.22, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
8.89
Change
0.06

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.717
Neutral
RSI(14)
69.300
Neutral
STOCH(KDJ)(9,3,3)
95.532
Overbought
ATR(14)
0.726
High Vlolatility
CCI(14)
129.827
Buy
Williams %R
2.312
Overbought
TRIX(12,20)
0.281
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
14.028
Buy
MA10
13.472
Buy
MA20
12.585
Buy
MA50
13.578
Buy
MA100
14.420
Buy
MA200
14.325
Buy

Institutional Confidence

Currency: USD Updated: 2025-11-07

The company’s current institutional recognition score is 5.00, which is lower than the Professional & Commercial Services industry's average of 6.93. The latest institutional shareholding proportion is 51.83%, representing a quarter-over-quarter decrease of 46.84%. The largest institutional shareholder is The Vanguard, holding a total of 919.55K shares, representing 4.06% of shares outstanding, with 1.29% decrease in holdings.

Score

Industry at a Glance

Previous score
5.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Amandla MK Trust
4.76M
--
Common Property Trust LLC
3.85M
--
Kayne Anderson Rudnick Investment Management, LLC
2.99M
-1.25%
Hays (Michael D)
1.39M
+1326.95%
The Vanguard Group, Inc.
Star Investors
919.55K
-1.44%
BlackRock Institutional Trust Company, N.A.
862.15K
-8.71%
Atlanta Capital Management Company, L.L.C.
704.75K
-6.46%
Dimensional Fund Advisors, L.P.
531.20K
-4.17%
Green (Trent S.)
500.00K
--
Geode Capital Management, L.L.C.
404.30K
-9.47%
1
2

Risk Assessment

Currency: USD Updated: 2025-11-07

The company’s current risk assessment score is 4.49, which is lower than the Professional & Commercial Services industry's average of 5.57. The company's beta value is 0.47. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
4.49
Change
0
Beta vs S&P 500 index
0.47
VaR
+3.85%
240-Day Maximum Drawdown
+48.76%
240-Day Volatility
+54.96%

Return

Best Daily Return
60 days
+16.02%
120 days
+16.02%
5 years
+16.02%
Worst Daily Return
60 days
-7.70%
120 days
-7.70%
5 years
-16.47%
Sharpe Ratio
60 days
-0.19
120 days
+0.43
5 years
-0.37

Risk Assessment

Maximum Drawdown
240 days
+48.76%
3 years
+78.35%
5 years
+81.00%
Return-to-Drawdown Ratio
240 days
-0.50
3 years
-0.25
5 years
-0.17
Skewness
240 days
+0.29
3 years
-0.24
5 years
-0.37

Volatility

Realised Volatility
240 days
+54.96%
5 years
+39.84%
Standardised True Range
240 days
+4.85%
5 years
+7.50%
Downside Risk-Adjusted Return
120 days
+78.55%
240 days
+78.55%
Maximum Daily Upside Volatility
60 days
+50.00%
Maximum Daily Downside Volatility
60 days
+29.81%

Liquidity

Average Turnover Rate
60 days
+0.44%
120 days
+0.42%
5 years
--
Turnover Deviation
20 days
+27.05%
60 days
+21.28%
120 days
+15.40%

Peer Comparison

Professional & Commercial Services
National Research Corp
National Research Corp
NRC
5.38 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
S&P Global Inc
S&P Global Inc
SPGI
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Huron Consulting Group Inc
Huron Consulting Group Inc
HURN
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Deluxe Corp
Deluxe Corp
DLX
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Genpact Ltd
Genpact Ltd
G
8.36 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brinks Co
Brinks Co
BCO
8.34 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI